Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 29, 2026
Venous Thromboembolism in Women with Breast and Gynaecological Cancers: What Do We Know and What Should We Do?Geraldine Poenou, Pauline Corbaux, Sandrine Accassat, et al.Cancers|March 29, 2023
HER2-Positive Metastatic Breast Cancer: Available Treatments and Current DevelopmentsIsmail Essadi, Zineb Benbrahim, Mohamed Kaakoua, et al.Medicina (Kaunas, Lithuania)|February 26, 2025
Cutaneous Anguillulosis During Immunotherapy for Metastatic Renal Cell CarcinomaPierre Cornillon, Marie Beguinot, Denis Maillet, et al.European Journal of Cancer (Oxford, England : 1990)|September 4, 2019
Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapiesPauline Corbaux, Mévidette El-Madani, Michel Tod, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 25, 2025
Hydration practices during cisplatin administration: a national multicenter surveyPaul Matte, Arnaud Saillant, Pauline Corbaux, et al.International Journal of Clinical Oncology|January 16, 2023
Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysisPauline Corbaux, Catherine Terret, Claire Cropet, et al.Nutrition and Cancer|May 10, 2019
Is Nutritional Screening of Patients with Lung Cancer Optimal? An Expert Opinion Survey of French Physicians and SurgeonsPauline Corbaux, Clara Fontaine-Delaruelle, Pierre-Jean Souquet, et al.Future Oncology (London, England)|August 31, 2023
NIRVANA-1: maintenance therapy with niraparib versus niraparib-bevacizumab in patients with advanced ovarian cancerSyrine Sghaier, Pauline Corbaux, Isabelle Ray-Coquard, et al.European Journal of Cancer (Oxford, England : 1990)|October 8, 2019
Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life settingPauline Corbaux, Denis Maillet, Amélie Boespflug, et al.Biomedicines|January 21, 2023
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective StudyMadeleine Maugeais, Julien Péron, Stéphane Dalle, et al.Pageof 3